Driehaus Capital Management LLC Reata Pharmaceuticals Inc Transaction History

Driehaus Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $7.52 Million - $10 Million	94,945 New	94,945 $9.68 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $1.59 Million - $2.22 Million	-12,558 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $464,358 - $926,547	-3,740 Reduced 22.95%	12,558 $1.81 Million
Q4 2019 Feb 12, 2020	SELL	$74.57 - $217.92 $14.7 Million - $42.9 Million	-197,077 Reduced 92.36%	16,298 $3.33 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $1.66 Million - $2.23 Million	-23,264 Reduced 9.83%	213,375 $17.1 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $7.14 Million - $8.66 Million	91,817 Added 63.4%	236,639 $22.3 Million
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $857,543 - $1.68 Million	16,523 Added 12.88%	144,822 $12.4 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $2.85 Million - $4.47 Million	-58,528 Reduced 31.33%	128,299 $7.2 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $6.66 Million - $17.2 Million	186,827 New	186,827 $15.3 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.